{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-064291","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2026-02-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.208574+00:00","generated_at":"2026-05-16T01:13:51.598422+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ORIC files new $200M ATM offering; prior program fully utilized","bullets":["New prospectus supplement filed Feb 26, 2026 for up to $200M in shares via Jefferies.","Prior $200M program (2024) terminated after raising $139.7M gross from 13.48M shares.","No further sales will be made under the 2024 prospectus supplement.","Legal opinion from Wilson Sonsini filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-064291","json":"https://secwatch.observer/filing/0001193125-26-064291.json","markdown":"https://secwatch.observer/filing/0001193125-26-064291.md","text":"https://secwatch.observer/filing/0001193125-26-064291.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312526064291/0001193125-26-064291-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312526064291/d25338d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T01:13:51.598422+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}